Q-bios
Private Company
Funding information not available
Overview
Q-bios is a privately held, revenue-generating German biotech firm that serves as a specialized supplier and service provider in the life sciences tools sector. Its core business revolves around manufacturing high-quality DNA polymerases, reverse transcriptases, and ready-to-use master mixes for PCR applications, alongside offering custom recombinant protein production and OEM services. The company leverages over a decade of expertise in molecular biology and protein science, targeting industrial clients in diagnostics, pharma, and biotechnology with a 'Made in Germany' production and quality assurance ethos. While not developing its own therapeutic or diagnostic products, it provides critical enabling reagents and services that support R&D and production workflows for its customers.
Technology Platform
Recombinant protein and enzyme production platform specializing in thermostable DNA polymerases, reverse transcriptases, and formulation of optimized PCR/qPCR/RT-qPCR master mixes. Capable of custom protein design and production for OEM clients.
Opportunities
Risk Factors
Competitive Landscape
Q-bios competes in the crowded life science reagents market, facing off against multinational giants like Thermo Fisher Scientific, Qiagen, and Bio-Rad, as well as numerous other specialized enzyme suppliers. Its differentiation is based on customization, high-quality 'Made in Germany' production, and personalized service, targeting clients who may find larger suppliers less flexible.